PTPRC and psoriasis: Interestingly, topical treatment of the psoriatic skin with placebo, but not diacerein, significantly reduced the overall fraction of CD45+ cells in the spleen and skin compared to untreated psoriasis (p = 0.0017 and p = 0.0122;) (Figure 3A and Figure 4A).